SCHEMBL5344736

SCHEMBL5344736

c1ccc2c(c1)-c1ccccc1C21c2cccnc2-c2ncccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.49
KMT2A Q03164 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 1/20 0.47
PTPRC P08575 2/20 0.45
CTSL P07711 1/20 0.45
CTSS P25774 1/20 0.45
PTPN13 Q12923 1/20 0.45
MEN1 O00255 2/20 0.45
GAA P10253 2/20 0.45
TDP2 O95551 2/20 0.45
NSD2 O96028 2/20 0.45
PAX8 Q06710 2/20 0.45
ABL1 P00519 1/20 0.45
PLCG1 P19174 1/20 0.45
CES1 P23141 1/20 0.45
RIN1 Q13671 1/20 0.45
THRB P10828 1/20 0.45
BLM P54132 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32682807 1.00 PDK2 (0.49) PDK2KMT2ACYP1A2CYP2C19PTPRC
SCHEMBL29419598 1.00 PDK2 (0.49) PDK2KMT2ACYP1A2CYP2C19PTPRC
SCHEMBL11990868 0.94 PDK2 (0.56) PDK2KMT2ACYP1A2CYP2C19PTPRC
SCHEMBL30322608 0.94 PDK2 (0.56) PDK2KMT2ACYP1A2CYP2C19PTPRC
SCHEMBL11990870 0.89 PDK2 (0.42) PDK2KMT2ACYP1A2CYP2C19PTPRC
SCHEMBL31342912 0.85 PDK2 (0.39) PDK2KMT2ACYP1A2CYP2C19PTPRC
SCHEMBL31292796 0.85 PDK2 (0.39) PDK2KMT2ACYP1A2CYP2C19PTPRC
SCHEMBL31292879 0.85 PDK2 (0.45) PDK2KMT2ACYP1A2CYP2C19PTPRC
SCHEMBL12175964 0.85 SMN1; SMN2 (0.46) PDK2KMT2ACYP1A2CYP2C19PTPRC
SCHEMBL12983101 0.85 PDK2 (0.52) PDK2KMT2ACYP1A2CYP2C19PTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-06 US disclosed
CN-111848588-B Organic compound, and electronic element and electronic device using same 陕西莱特光电材料股份有限公司 2021-11-16 CN disclosed
US-20210163411-A1 COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) 2021-06-03 US disclosed
CN-111848588-A Organic compound, and electronic element and electronic device using same 陕西莱特光电材料股份有限公司 2020-10-30 CN disclosed
US-10597403-B2 Condensed cyclic compound, composition including the condensed cyclic compound, organic light-emitting device including the condensed cyclic compound, and method of manufacturing the organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-24 US disclosed
US-9758688-B2 Composition for forming conductive film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-09-12 US disclosed
US-9758688-B2 Composition for forming conductive film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-09-12 US disclosed
US-9704612-B2 Composition of silver-conjugated compound composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-11 US disclosed
US-9704612-B2 Composition of silver-conjugated compound composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-11 US disclosed
EP-3184522-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE Samsung Electronics Co., Ltd. (KR) 2017-06-28 EP disclosed
US-20090236974-A1 ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-09-24 US disclosed
US-7282586-B1 Dipyridine-based compound and the use thereof LUMINESCENCE TECHNOLOGY CORP. (TW) 2007-10-16 US disclosed
US-7282586-B1 Dipyridine-based compound and the use thereof LUMINESCENCE TECHNOLOGY CORP. (TW) 2007-10-16 US disclosed
US-7282586-B1 Dipyridine-based compound and the use thereof LUMINESCENCE TECHNOLOGY CORP. (TW) 2007-10-16 US disclosed
US-20060186797-A1 Pi-conjugated compound having cardo structure, process for preparing same and use of same TOSOH CORPORATION (JP) 2006-08-24 US disclosed
EP-1690847-A1 pi-Conjugated compound having cardo structure, process for the preparation thereof and use thereof Tosoh Corporation (JP) 2006-08-16 EP disclosed
EP-0894107-B1 COMPOUNDS WITH SPIRO ATOMS AND THEIR USE AS ELECTROLUMINESCENT MATERIALS AVENTIS RES & TECH GMBH & CO (DE) 1999-12-22 EP disclosed
EP-0894107-A1 POLYMERS WITH SPIRO ATOMS AND THEIR USE AS ELECTROLUMINESCENT MATERIALS Hoechst Research & Technology Deutschland GmbH & Co. KG (DE) 1999-02-03 EP disclosed
US-5763636-A CONJUGATED POLYCYCLIC POLYMERS HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-09 US disclosed
WO-1997039045-A1 POLYMERS WITH SPIRO ATOMS AND THEIR USE AS ELECTROLUMINESCENT MATERIALS HOECHST RESEARCH & TECHNOLOGY DEUTSCHLAND GMBH & CO. KG (DE) 1997-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217825-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME OR10J3, AOC2, EPCAM PDK2 1256/4885KMT2A 1952/4885CYP1A2 585/4885
US-20060186797-A1 Pi-conjugated compound having cardo structure, process for preparing same and use of same ARL1, TERB1, LEO1 PDK2 3990/4885KMT2A 1462/4885CYP1A2 328/4885
US-20210163411-A1 COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR WEE1, WEE2, ALOX12 PDK2 1307/4885KMT2A 1696/4885CYP1A2 733/4885
US-10597403-B2 Condensed cyclic compound, composition including the condensed cyclic compound, organic light-emitting device including the condensed cyclic compound, and method of manufacturing the organic light-emitting device CRY1, C9, CRY2 PDK2 1819/4885KMT2A 2550/4885CYP1A2 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.